Paper · 2009 · Open access
Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?
PubMed, 6(6), 29–37 · Published 1 June 2009
In brief
“Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?” is a 2009 paper by Ronald W. Pies, published in PubMed. OpenAlex counts 28 citations as of 20 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 28
- Most cited in
- 2022 (4)
- Field-weighted impact
- 1.13
- References
- 40
- Authors
- 1
Abstract
There is neurobiologically based, theoretical support for the use of antipsychotic medications in the treatment of anxiety, and two first-generation neuroleptics are approved by the United States Food and Drug Administration for the treatment of nonpsychotic anxiety. However, neuroleptics are associated with a large side effect burden, which has limited their utility in the treatment of nonpsychotic disorders. Because of their somewhat improved safety profile, atypical antipsychotics are increasingly used for the treatment of nonpsychotic anxiety. The published literature describing the efficacy of atypical antipsychotics in randomized, controlled trials involving patients with anxiety disorders is briefly reviewed, and the safety of atypical antipsychotics in nonpsychotic disorders is discussed. There is moderately strong controlled evidence supporting the use of some atypical antipsychotics, either as adjunctive treatment or monotherapy, in the treatment of nonpsychotic anxiety; however, the side effect burden of some atypical antipsychotics probably outweighs their benefits for most patients with anxiety disorders. The evidence to date does not warrant the use of atypical antipsychotics as first-line monotherapy or as first- or second-line adjunctive therapy in the treatment of anxiety disorders. Rigorous, independently funded, long-term studies are needed to support the off-label use of atypical antipsychotics in the treatment of anxiety disorders. Nevertheless, some patients with highly refractory anxiety disorders may benefit from the judicious and carefully monitored use of adjunctive atypical antipsychotics. A careful risk-benefit assessment must be undertaken by the physician, on a case-by-case basis, with appropriate informed consent.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pies, R. W. (2009). Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety? PubMed, 6(6), 29–37. https://pubmed.ncbi.nlm.nih.gov/19724759
MLA 9
Pies, Ronald W. “Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?” PubMed, vol. 6, no. 6, 2009, pp. 29–37. https://pubmed.ncbi.nlm.nih.gov/19724759.
Chicago
Pies, Ronald W. 2009. “Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?” PubMed 6 (6): 29–37. https://pubmed.ncbi.nlm.nih.gov/19724759.
Harvard
Pies, R. W. (2009) ‘Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?’, PubMed, 6(6), pp. 29–37. Available at: https://pubmed.ncbi.nlm.nih.gov/19724759.
IEEE
R. W. Pies, “Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?,” PubMed, vol. 6, no. 6, pp. 29–37, 2009.
BibTeX
@article{pies2009should,
title = {{Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?}},
author = {Pies, Ronald W.},
journal = {PubMed},
year = {2009},
volume = {6},
number = {6},
pages = {29--37},
url = {https://pubmed.ncbi.nlm.nih.gov/19724759}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2014 | 1 | |
| 2015 | 3 | |
| 2016 | 1 | |
| 2017 | 2 | |
| 2018 | 2 | |
| 2020 | 1 | |
| 2021 | 3 | |
| 2022 | 4 | |
| 2023 | 3 | |
| 2024 | 3 |
Its field-weighted citation impact is 1.13: it has been cited 1.13 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- atypical antipsychotics
- anxiety disorders
- off-label drug use
- adjunctive therapy
- monotherapy
- antipsychotic drugs
- treatment efficacy
- risk-benefit assessment
Work with this paper
Most-cited papers in Psychology
- Diagnostic and Statistical Manual of Mental DisordersAndrés Santiago González Moreno · American Psychiatric Association Publishing eBooks · 2013 · 123,932 citations
- The theory of planned behaviorIcek Ajzen · Organizational Behavior and Human Decision Processes · 1991 · 106,482 citations
- Self-efficacy: Toward a unifying theory of behavioral change.Albert Bandura · Psychological Review · 1977 · 61,923 citations
- Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.Richard M. Ryan, Edward L. Deci · American Psychologist · 2000 · 55,457 citations
- Mind in Society: The Development of Higher Psychological ProcessesL. S. Vygotsky · 기초학문자료센터(KRM) (Korea Research Foundation) · 1978 · 53,340 citations
Questions about this paper
How do I cite this paper in APA style?
Pies, R. W. (2009). Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety? PubMed, 6(6), 29–37. https://pubmed.ncbi.nlm.nih.gov/19724759
How many times has this paper been cited?
28 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Ronald W. Pies.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.